AI assistant
Sending…
Transcenta Holding Limited — Board/Management Information 2021
Sep 28, 2021
51014_rns_2021-09-27_3f79bc23-7f65-4084-8786-d6e4ab7ae999.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [137 x 41] intentionally omitted <==
Transcenta Holding Limited 創勝集團醫藥有限公司
(registered by way of continuation in the Cayman Islands with limited liability)
(Stock Code: 6628)
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
The members of the board of directors (the “ Board ”) of Transcenta Holding Limited (the “ Company ”) are set out below.
Executive directors
Dr. Xueming Qian (錢雪明) (Chief Executive Officer)
Dr. Michael Ming Shi (石明)
- Mr. Albert Da Zhu (朱達)
Non-executive director
Dr. Yining (Jonathan) Zhao (趙奕寧) (Chairman)
Independent non-executive directors
Mr. Jiasong Tang (唐稼松)
Dr. Jun Bao (包駿)
- Mr. Zhihua Zhang (張志華)
The Board has three committees. The table below details membership of these committees.
| Director | Auditcommittee | Remunerationcommittee | Nominationcommittee |
|---|---|---|---|
| Dr. Xueming Qian (錢雪明) | Member | ||
| Dr. Michael Ming Shi (石明) | |||
| Mr. Albert Da Zhu (朱達) | |||
| Dr. Yining (Jonathan) Zhao (趙奕寧) | Member | ||
| Mr. Jiasong Tang (唐稼松) | Chairperson | Member | |
| Dr. Jun Bao (包駿) | Chairperson | Member | |
| Mr. Zhihua Zhang (張志華) | Member | Member | Chairperson |
September 28, 2021
More from Transcenta Holding Limited
Regulatory Filings
2026
Jun 4
Regulatory Filings
2026
Jun 4
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 7
Report Publication Announcement
2026
Apr 28
Report Publication Announcement
2026
Apr 28
Environmental & Social Information
2026
Apr 28
Annual Report
2026
Apr 28